Amylyx Pharmaceuticals, Inc. (AMLX) — Revenue

Annual figures by fiscal year, from SEC filings.

2022: $22.23M2023: $380.79M2024: $87.37M2025: $0$0
2022Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$0-100.0%
2024$87.37M-77.1%
2023$380.79M+1612.9%
2022$22.23M